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Coronary bypass surgery improves global and 
regional left ventricular function following 
thrombolytic therapy for acute myocardial 
infarction 
Coronary bypass surgery was performed prior to hospital discharge in 303 (22%) of 1387 
consecutive patients enrolled in the TAMI 1 to 3 and 5 trials of intravenous thromboiytlc therapy 
for acute myocardial infarction. Bypass surgery was of emergency nature (<24 hours from 
treatment with intravenous thrombolytic therapy) in 38 (2.8%) and was deferred (>24 hours) in 
267 (19.3%) patients. The Indications for bypass surgery included failed angloplasty (12%); left 
main or equivalent coronary disease (9%); complex or multivessel coronary disease (62%); 
recurrent postinfarction angina (13%); and refractory pump dysfunction, mitral regurgitation, 
ventricular septal rupture or abnormal predischarge functional test (1% each). Although patients 
having bypass surgery were older (59.5 + 9.8 versus 56.0 +- 10.2 years, (p < O.OOOl), had more 
extensive coronary artery disease (46% with three-vessel disease versus 1 l%, @ < O.OOOl), had 
more frequent diabetes mellitus (19% versus 15%, (p = 0.048), had more prior infarctions 
(p < O.OOOl), had more severe initial depression in global left ventricular ejection fraction 
(48.0 f 11.9% versus 51.8 f 11.9%, p = 0.0002), and regional infarct zone (-2.7 k 0.94 versus 
-2.5 + 1.1 SD/chord, p = 0.02) and noninfarct zone function (-0.36 It_ 1.8 versus 0.43 k 1.6 
SD/chord, p < 0.0001) than patients not having coronary bypass surgery, no difference in the 
incidence of death in hospital (7% surgical versus 6% nonsurgical) or death at long-term 
follow-up of hospital survivors (7% surgical versus 6% nonsurgical) was noted between groups. 
Surgical patients demonstrated a greater degree of recovery In left ventricular ejection fraction 
(3.4 2 9.8% versus 0.16 + 8.5%, p = 0.036) and infarct zone regional function (0.71 + 1.1 
versus 0.34 k 0.99 SD/chord, p = 0.001) when immediate (90 minutes following initiation of 
thrombolytic therapy) and predischarge (7 to 14 days after treatment) contrast left 
ventriculograms were compared than did patients who received only intravenous thrombolytic 
therapy with or without coronary angioplasty. These data suggest a beneficial influence of 
coronary bypass surgery on left ventricular function and possibly on the clinical outcome of 
patients initially treated with intravenous thrombolytic therapy for acute myocardial Infarction (AM 
HEART J 1991;122:390.) 
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4l1l30-753 
Coronary bypass surgery has served both primarylV5 
and adjunctive role@? 7 in strategies directed toward 
myocardial reperfusion during acute myocardial in- 
farction. Although immediate and long-term results 
of bypass surgery performed early during the evolu- 
tion of myocardial infarction have been promising49 5 
practical, logistic, and financial considerations have 
limited widespread application of this approach. The 
administration of intravenous thrombolytic therapy 
early in acute myocardial infarction has been dem- 
onstrated to be successful in achieving infarct artery 
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reperfusion in a majority of patients and in improv- 
ing myocardial function as well as reducing hospital 
and long-term (1 year) mortality following infarc- 
tion.8-11 These salutary effects, in addition to the ease 
and rapidity of administration, have established in- 
travenous thrombolysis as the standard of care in 
suitable patients with acute myocardial infarction. 
However, intravenous thrombolysis fails to achieve 
infarct artery recanalization in 25% or more of 
patients,12 and coronary reocclusion following suc- 
cessful thrombolysis may also limit the potential 
gains to be achieved with this treatment.13 Late 
(greater than 6 hours) coronary thrombolysis or the 
establishment of myocardial reperfusion by mechan- 
ical or surgical methods following failed thromboly- 
sis may also have a long-term beneficial influence by 
facilitating myocardial healing, reducing infarct ex- 
pansion, and enhancing electrical stability.14-l6 These 
effects may be associated with a reduction in mortal- 
ity even in the absence of measurable improvements 
in global and infarct zone regional left ventricular 
function.14, l7 
We6 have previously evaluated the adjunctive role 
of bypass surgery in a small subset of patients hav- 
ing emergency surgery as part of a sequential reper- 
fusion strategy following thrombolytic therapy for 
myocardial infarction. In this sequence, bypass sur- 
gery was not utilized to initiate myocardial reperfu- 
sion but was used instead to maintain reperfusion 
that had been established by pharmacologic or bal- 
loon catheter techniques. The purpose of the present 
study was (1) to evaluate the immediate and long- 
term clinical outcomes of patients with and without 
coronary bypass surgery performed as part of a 
sequential reperfusion strategy during the initial 
hospitalization for acute myocardial infarction and 
(2) to evaluate the influence of coronary bypass sur- 
gery on global and regional left ventricular function. 
METHODS 
From January 1986 through June 1990, coronary bypass 
surgery was performed before hospital discharge on 303 
(22 ‘?;I ) of 1387 patients enrolled in the Thrombolysis and 
Angioplasty in Myocardial Infarction (TAMI) 1 to 3 and 5 
trials. Details of study design have been described 
previously.i2s 1s-21 Enrollment criteria included chest pain 
of less than 6 hours’ duration and 21 mm ST segment el- 
evation in two or more contiguous electrocardiographic 
leads. Exclusion criteria included age >75 years; history of 
recent stroke, surgery or trauma; previous history of hem- 
orrhagic disorder; prior coronary bypass surgery; prior Q 
wave infarction in the acutely ischemic region; and cardio- 
genie shock (blood pressure <85 mm Hg unresponsive to 
volume infusion). 
Thrombolytic regimens 
TAMI 1. In the first 178 patients enrolled, the dose of 
tissue plasminogen activator was 60 mg during the first 
hour, 20 mg per hour during the second and third hours, 
and 10 mg for each of the last 5 hours. In the remaining 208 
patients, the dose during the first hour was 1.0 mglkg of 
body weight, with a maximum of 90 mg: the remaining 
amount (of a total of 150 mg) was given in equal amounts 
per hour over a 5-hour maintenance infusion.i2 
TAMI 2. Five dose increments of combined tissue plas- 
minogen activator and urokinase were administered in 
TAM1 2. In groups I and II, 25 mg of tissue plasminogen 
activator was administered with 0.5 and 1.0 million units of 
urokinase. In groups 3, 4, and 5, 1.0 mg/kg of tissue plas- 
minogen activator (maximum 90 mg) with 10% given as a 
bolus was administered with 0.5,1.0, and 2.0 million units 
of urokinase, respectively.‘s 
TAMI 2A (Duke University urokinase protocol). Pa- 
tients received 3 million units of intravenous urokinase 
over 45 to 60 minutes. In 42 patients, 1.5 million units of 
urokinase was given as a bolus followed by 1.5 million units 
infused over 45 to 60 minutes, and in 60 patients 3.0 mil- 
lion units was administered by continuous infusion without 
a bolus dose.lg 
TAMI 3. Patients received 1.5 mg/kg tissue plasminogen 
activator intravenously over 4 hours. The dose was 1.0 mg/ 
kg over the first hour with 10% given as a bolus to a max- 
imum first-hour dose of 90 mg. Over the next 3 hours, 0.5 
mg/kg was given, not to exceed a total maintenance infu- 
sion of 45 mg. Patients were randomly assigned to receive 
either 10,000 units intravenous heparin or no heparin 
concurrently.20 
TAMI 5. Patients were randomly assigned to receive in- 
travenous urokinase, tissue plasminogen activator, or the 
combination. Urokinase was given as a 1.5 million unit in- 
travenous bolus followed by a 1.5 million unit infusion over 
90 minutes. Tissue plasminogen activator was given as 60 
mg in the first hour with 6 mg as a bolus, and a 20 mg in- 
fusion each hour for the next 2 hours for a total dose of 100 
mg. The combined therapy arm consisted of 1.5 million 
units of urokinase over 60 minutes with 1 mg/kg of tissue 
plasminogen activator, 10% given as a bolus, and a maxi- 
mum dose of 90 mg over 60 minutes. Combined throm- 
bolytic therapy was given simultaneously via two separate 
intravenous lines.21 
Interventional protocol. Informed consent was obtained 
from patients prior to their treatment with intravenous 
thrombolytic therapy. In TAM1 1 to 3, all patients under- 
went selective coronary angiography of the infarct-related 
artery and left ventricular angiography at 90 minutes fol- 
lowing the initiation of intravenous thrombolytic therapy. 
Final infarct-related artery patency was determined after 
the fourth contrast injection, according to the classification 
of the Thrombolysis In Myocardial Infarction (TIMI) 
tria1.22 Patients with persistent infarct-related artery oc- 
clusion (TIM1 0 to 1) and suitable coronary anatomy were 
offered salvage angioplasty. In TAM1 1., coronary angio- 
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Table I. Clinical findings in patients with and without coronary bypass surgery 
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*p < 0.0001 all surgery versus no surgery; p = 0.08 emergency versus deferred. 
tp = 0.048 all versus no surgery. 
$p < 0.0001 all surgery versu8 no surgery. 
Sp = 0.059 all versus no surgery; p = 0.002 emergency versus deferred. 
lip = 0.074 emergency versus deferred. 
plasty was performed for the following indications: (1) pa- 
tients with suitable coronary anatomy and a >50% resid- 
ual stenosis accompanied by TIM1 2 to 3 flow were 
randomly assigned to either immediate or deferred (7 to 10 
days) coronary angioplasty and (2) patients with persistent 
infarct-related coronary occlusion (TIM1 0 to 1 flow) and 
suitable coronary anatomy. l2 Following the experience of 
TAM1 1, angioplasty was not performed immediately in 
subsequent trials if TIM1 2 to 3 flow was achieved pharma- 
cologically and was offered only to patients with persistent 
infarct-related artery occlusion and suitable coronary anat- 
omy. In TAM1 5, patients were randomly assigned to either 
an “aggressive” catheterization strategy with angiography 
performed within 90 minutes of initiation of thrombolytic 
therapy or to a “deferred-elective” procedure with angiog- 
raphy performed at 7 to 10 days following thrombolytic 
therapy. In the “aggressive” catheterization strategy, if 
pharmacologic thrombolysis had failed, rescue angioplasty 
was attempted if the vessel was suitable in the judgment of 
the investigator. Contraindications to angioplasty included 
left main stem stenosis in patients with left coronary in- 
farct vessel location or lack of adequate identification of the 
culprit coronary artery in the setting of multiple vessel oc- 
clusion. In the “deferred” cardiac catheterization strategy, 
patients were eligible for urgent crossover catheterization 
if recurrent signs or symptoms of myocardial ischemia, hy- 
potension, pulmonary edema, or a new holosystolic mur- 
mur were evident. 
In the event that angioplasty was unsuccessful in main- 
taining coronary patency, a coronary perfusion catheter or 
perfusion balloon catheter was placed over an exchange 
guide wire and was intermittently flushed with heparinized 
solution. These catheters were utilized to maintain coro- 
nary flow en route to coronary bypass surgery. Not all pa- 
tients with unsuccessful immediate coronary angioplasty 
had emergency coronary bypass surgery. Patients were as- 
sessed on an individual basis for clinical data suggesting a 
large, viable, jeopardized myocardial bed or severe multi- 
vessel coronary artery disease. The decision to perform 
emergency coronary bypass surgery was at the discretion of 
the principal investigator. Surgery was considered an 
emergency if it was performed within 24 hours of initiation 
of intravenous thrombolytic therapy and was considered 
“deferred” if it was performed more than 24 hours follow- 
ing thrombolysis. Patients having complex or severe mul- 
tivessel coronary artery disease who were thought to be 
poor candidates for percutaneous transluminal coronary 
angioplasty were considered for deferred bypass surgery. 
Coronary bypass surgery was performed using standard 
aortic cross-clamping techniques and cold potassium car- 
dioplegia. 
Data collection and management. Findings in the tri- 
als were collected by the study nurses and were reviewed 
by the principal investigator at each clinical site. Data for 
each patient were subjected to a rigorous process of cross- 
checking with medical record source documentation by 
trained data monitors. Computer entry and management 
of study data were performed at the TAM1 data coordi- 
nating center. All survivors of hospital discharge were fol- 
lowed for at least 1 year or until death. These patients were 
contacted by telephone and were asked to complete stan- 
dardized questionnaires regarding general health status, 
angina status, and return to work. 
Statistical analysis. Continuous baseline clinical char- 
acteristics of surgically and nonsurgically treated patients 
were summarized using the mean + standard deviation. In 
instances where the distribution was skewed, the median 
and selected percentiles were used. Discrete variables were 
characterized in terms of frequencies and percentages. 
Statistical comparisons between groups were performed 
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Table II. Angiographic findings 
Emergency 
(n = 36) 
Type of surgery 
_- 
Deferred All None 
(n = 267) (n = 303) (n = 1084) 
Infarct artery 
Left anterior descending 
Left, circumflex 
Right coronary 
Left main coronary 





Multivessel disease (22 vessels)* 











*p < 0.0001 all surgery versus none. 
tp < 0.0001 all surgery versus none; p < 0.0001 emergency versus deferred surgery. 
using the Wilcoxon rank sum test in the case of continuous 
variables and the chi square test in the case of discrete 
variables. For global and regional measures of left ventric- 
ular function, comparisons between groups of the change in 
function (acute versus predischarge) were performed using 
linear regression analysis, adjusting the change for the 
value at the baseline (acute) study. All p values presented 
are based on two-tailed significance testing. 
Anelyeis of left ventrtculer function. Outlines of right 
anterior oblique contrast ventriculograms obtained at 90 
minutes following initiation of thrombolytic therapy and 
prior to hospital discharge were traced manually by an in- 
dependent observer, who was blinded to patient data at the 
Core Angiographic Laboratory at the University of Mich- 
igan. Left ventricular ejection fraction was determined by 
the area-length method.23 Regional wall motion was deter- 
mined by the computer-assisted center-line chord method 
of Rolson et al.24 and was expressed as standard deviations 
(SD) per chord. Representative end-diastolic and end-sys- 
tolic frames were digitized and stored in the memory of a 
digital radiographic computer (DPS 41OOC, Adac Labora- 
tories, Milpitas, Calif.) for processing. Ventriculograms 
considered technically inadequate because of ventricular 
ectopic beats or inadequate opacification were not included 
in the analysis. 
RESULTS 
Coronary bypass surgery was performed on 303 
(22%) of 1387 consecutive patients enrolled in the 
TAMI 1 to 3 and 5 trials. Surgery was of emergency 
nature in 36 (2.6%) and was deferred (>24 hours) in 
267 patients (19.3%). The clinical features of the 
NW&& patients are compared in Table I with thtie 
of the 1034 p&ients (78% ) who did not have surgery 
during the initial hospit&Wion for acute myocar- 
dial infarction. As a group, patients having surgery 
were older (p < O.OOOl), more often had diabetes 
Table III. Indications for bypass surgery 
Type of surgery 
Emergency Deferred 
Indication NO. (%.I No. 06) 
Failed PTCA 14 (39) 21 (8) 
Left main/Equivalent disease 7 (19) 21 (8) 
Complex coronary anatomy 11 (31) 176 (66) 
Recurrent angina 4 (11) 35 (13) 
Refractory pump dysfunction 0 5 (2) 
Mitral regurgitation 0 3 (1) 
Ventricular septal rupture 0 3 (1) 
Abnormal functional study 0 3 0) 
PTCA, Percutaneous transluminal coronary angioplasty. 
mellitus (p = O&48), more often had d prior infarc- 
tion (p < O.OOOl), and bed mar 
shock early folluwing throm 
0.059) thslri patientxs who did nut 
The ditribution of anterior m 
infarct-relatsd artery loo&ion, 
diseased coronary V~GN~ for b&h group am shown 
Surgical patients hsd more extensive 
coronary disease 0, < 0.9661) than non- 
surgical patienta. The clinical indiW,ti for surgery 
function value) are &own in Pi. 1. I 
t&&grams suitable for analysis were available from 




l P = .0002 
l * P = .03 
0 NO SURGERY 
PREDISCHARGE CHANGE IN LVEF 
Fig. 1. Immediate and predischarge left ventricular ejection fraction (LVEF) and absolute change in 
LVEF between paired studies for patients with and without coronary bypass surgery. Surgical patients had 
more depressed immediate left ventricular function and a greater increment in LVEF before hospital dis- 
charge. 
193 of 303 (64% ) of surgical patients (25 of 36 emer- 
gency patients; 168 of 267 deferred patients) and 
from 720 of 1084 (66% ) of nonsurgical patients. 
Suitable predischarge studies were obtained from 
194 of 283 (69% ) surgical survivors (17 of 30 emer- 
gency patients, 177 of 253 deferred patients) and 
from 840 of 1020 (82% ) of nonsurgical patients. Sur- 
gical patients had a greater depression in initial left 
ventricular ejection fraction (48.0 +- 11.9% versus 
51.8 + 11.9% ; p = 0.0002), initial infarct zone 
(-2.7 + 0.94 versus -2.5 2 1.1 SD/chord; p = 0.02) 
and noninfarct zone function (-0.36 + 1.8 versus 
0.43 + 1.6 SD/chord; p < 0.0001) than nonsurgical 
patients (Figs. 1 and 2). At predischarge angiographic 
follow-up, no significant difference in left ventricular 
ejection fraction (51.6 -t 11;8% versus 52.8 -+- 11.3% ; 
p = 0.20) or infarct xone function (-2.1 -+ 1.3 versus 
-2.3 & 1.2 SD/chord; p = 0.12) between surgical and 
nonsurgical groups were noted, Late angiographic 
evaluation demonstrated a persistent sign&ant dif- 
ference in noninfarct zone function between groups 
(-0.17 k 1.6 surgical versus 0.35 f 1.3 SD/chord for 
nonsurgical patients; p < 0.0001). After adjustment 
for initial or immediate values of function, surgical 
patienta demonstrated a greater degree of recovery in 
global ejection fraction and regional (infarct zone) 
function than patients not having bypass surgery. 
The changes in left ventricular ejection fraction in 
surgical and nonsurgical patients were 3.4 k 9.8% 
versus 0.16 + 8.5% (p = 0.036) and in infarct zone 
regional function the changes were 0.71 f 1.1 versus 
0.34 it 0.99 SD/chord @ = O.OOl), respectively. No 
statistically significant difference with respect to 
change in noninfarct zone function was noted be- 
tween groups (0.30 +_ 1.3 surgical versus -0.17 St 1.1 
SD/chord nonsurgical; p = 0.15). 
The results of immediate and predischarge evalu- 
ation of left ventricular global and regional function 
for patients having emergency and deferred bypass 
surgery are shown in Figs. 3 and 4. Substantial 
recovery of both global left ventricular ejection frac- 
tion and infarct zone regional function was observed 
for both groups of surgical patients; however, no dif- 
ference with respect to the degree or extent of func- 
tional recovery was noted between groups. 
Hospital course. Perioperative hemodynamic sup- 
port with intravenous inotropic agents was required 
in 32% and intraaortic balloon pump counterpulsa- 
tion was required in 10 % of surgical patients. Despite 
the need for early hemodynamic support, 97 % of pa- 
tients survived the operative procedure. In-hospital 
death occurred with similar frequency in surgical 
(6.6% ) and nonsurgical (5.9 % ) patients. 
Post horpltal tollow=up. After a median follow-up of 
1092 days in surgical patients and 1099 days in non- 
surgical patients, the occurrence of death and recur- 
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CHANGE IN CHANGE IN NON- 
INFARCT ZONE PREDISCHARGE NON- 
INFARCT ZONE FUNCTION 
PREDISCHARGE 
INFARCT ZONE 
-4.0 - -2.7*.94 -2.5fl .l -2.1fl.3 
-2.3zkl.2 
Fig. 2. Immediate and predischarge infarct zone and noninfarct zone regional left ventricular function in 
patients with and without coronary bypass surgery (see text). 
rent nonfatal myocardial infarction was similar in 
both groups (Table IV). The need for revasculariza- 
tion procedures (bypass surgery and PTCA) was 
more frequent in patients who did not undergo sur- 
gical revascularization during the initial hospitaliza- 
tion (18% nonsurgical versus 7 % surgical group). 
Similarly, at a median follow-up of 1251 days for the 
emergency and 965 days for the deferred surgical 
groups, the incidence of death (4% emergency; 8% 
deferred) was not different and the need for repeat 
revas&&ration procedures was more frequent in 
patients who had undergone emergency (26 % ) versus 
deferred (6% ) surgery (Table IV). 
DtSCWSlON 
The present study evaluates both clinical out- 
comes and left ventricular function of patients un- 
dergoing coronary bypass surgery as part of a se- 
quential rep&u&on strategy for the treatment of 
acute myoeardial infarction and compares these 
findirrgs with those of patients enrolled into the same 
multicenter (TAMI) trials of intravenous throm- 
bolytic therapy who did not have bypass surgery 
perfarmed. Primary surgical reperfusion therapy for 
m-dial infarction was not evaluated in this 
study. 
t&t vent&x&r fun&ton. We have previously re- 
ported6 that emergency coronary bypass surgery em- 
ployed in a sequential reperfusion strategy following 
intravenous thrombolytic therapy for acute myocar- 
dial infarction was associated with substantial im- 
provements in global and regiozxal infar& zone left 
ventricular function. In this previous trial, as in the 
current study, surgery was not 
cardial reperfusion but instead 
perfusion that had been achieved b 
or balloon catheter tech&~ 
cases. When employed in this 
surgery (less than 6 hours versus m@e than 6 hours 
after infarct symptom onset) dii 
ence the degree of left 
recovery.e These res&ts are 
prior reports using p&hary 
apy for acute my&id i 
that patients operated <6 hours from the onset of 
symptoms had aignitlcantly gr#er mry of left 
ventricular function and improved survival in long- 
term follow-up? 5 
In the present study, 
severe depression in left 
as by immediate 
(Fig. 1). Comparison of 
grams dcmwutrated n 
tween left ventr 
group, thus rtsfiscting 
recovery in surgical 
marked recovery of &far& zone &aft ver&rMar 
function was oslservsd in 
adjustment for ti more 
zone finxctioa obeerved on 
this group (Fig. 2). As noted 
tients also demonstrated more severe depression in 
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LVEF% 
48.2 t11.7 
6o T EMERGENCY 
IMMEDIATE PREDISCHARGE CHANGE IN LVEF 
Fig. 3. Immediate and predischarge left ventricular ejection fraction (LVEF) for patients having emer- 
gency and deferred coronary bypass surgery. No significant differences in absolute LVEF or change in LVEF 
were observed. 
Table IV. Events post discharge 





6.2% 1.2% 3.7% 1.1% 
8.4% 5.3% 4.0% 5.6% 
10.2% 4.2% 12.0% 3.1% 
7.7% 3.2% 8.0% 2.5% 
CABG, Coronary artery bypass graft surgery; MI, myocardial infarction; other abbreviations as in Table III. 
noninfarct zone regional left ventricular function 
than did nonsurgical patients. This finding may in 
part be explained by the more frequent occurrence of 
multiveesel coronary artery disease in the surgical 
patients, leading to ischemic dysfunction in left ven- 
tricular regions distinct from the acute infarct zone.25 
Although no significant differences were noted be- 
tween surgical and nonsurgical patients with respect 
to predischarge left ventricular ejection fraction and 
regional infarct zone function as noted above, de- 
ferred noninfarct zone left ventricular function re- 
mained depressed in surgical patients. Unlike the 
changes observed for global ejection fraction and re- 
gional infarct zone function, no difference in the de- 
gree of change in noninfarct zone function was noted 
between groups. Individual group analysis revealed 
compensatory hyperfunction of the noninfarct zone 
on the immediate ventriculogram (0.43 it- 1.6 SD/ 
chord) that was persistent at the predischarge eval- 
uation (0.35 + 1.3 SD/chord) in nonsurgical pa- 
tients. Although some improvement in noninfarct 
zone function between early and late studies 
(-0.36 + 1.8 to -0.17 + 1.6 SD/chord) was observed 
in surgical patients, no statistically significant dif- 
ference was noted with respect to the magnitude of 
change between groups (0.30 -+ 1.3 versus -0.17 + 
1.1, surgical and nonsurgical groups, respectively). 
Thus the degree of recovery in both global and re- 
gional infarct zone left ventricular function noted in 
patients who underwent coronary bypass surgery as 
part of a sequential reperfusion strategy clearly 
exceeded the degree of functional recovery noted fol- 
lowing therapy with intravenous thrombolysis with 
or without coronary angioplasty. In addition, im- 
provement in global and regional (infarct zone) left 
ventricular function was observed whether surgery 
was performed on an emergency or deferred basis, 
and no differences were noted in the degree of func- 
tional recovery between surgical groups. 
Although some degree of enhancement in left ven- 
tricular function may be attributable to an increase 
in circulating catecholamines and to other factors 
following major cardiac surgery, the magnitude of 
such changes appears small in comparison with the 
improvement noted in the present series.26l 27 In ad- 
dition, any specific improvement in left ventricular 
function attributable to surgically-induced hormonal 
changes alone would at least in part be counterbal- 
anced by similar hormonal changes present second- 
ary to the stress of myocardial infarction in the non- 
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-1.6 t 1.4 
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.82 t 0.2 
.70 t 1.1 
PREDISCXARGE 1 T 51 t 1.1 
.27 t 1.3 
NON.INFARCT l- 
INFARCT ZONE INFARCT ZONE 
FUNCTION FUNCTION 
Fig. 4. Immediate and predischarge infarct zone and noninfarct zone regional left ventricular function in 
patients with emergency and deferred coronary bypass surgery. No significant differences in absolute re- 
gional function or change in regional function were observed. 
surgical patients. 28* 2g This contention is at least in 
part substantiated by the observation of persistent 
hyperfunction of noninfarct zone function noted late 
following discharge in the nonsurgical group. 
A more specific metabolic benefit attributable to 
surgical coronary revascularization is suggested by 
these observations. As the vast majority of surgical 
patients had established myocardial reperfusion pre- 
operatively, the velocity of reperfusion and the com- 
position of initial reperfusate could not be controlled 
and would not be expected to be different between 
groups. A cytoprotective or preservative effect of 
cardioplegia during or soon following the acute in- 
farction process may have enhanced functional re- 
covery. Prior reports have suggested the potential 
benefit of gradual reperfusion with a reperfusate low 
in calcium that contains the Krebs cycle intermedi- 
ates, glutamate and aspartate.30 Early recovery of 
regional (infarct zone) left ventricular function fol- 
lowing surgical revascularization in patients 8 hours 
after the onset of acute myocardial infarction has 
been demonstrated previously using techniques of 
controlled reperfusion. 3o These considerations may 
be most applicable to patients who have severe 
ischemic left ventricular dysfunction.“’ 
Prior reports have demonstrated improvement in 
left ventricular ejection fraction and regional infarct 
zone function when primary surgkal myocardial 
reperfusion is performed early (within 6 hours) but 
not later following infarct symptom onset4, 5 As 
noted previously, patients in the present surgical se- 
ries had infarct artery recanaWation by pharmaco- 
logic or balloon catheter techniqaues, with surgery 
performed more than 6 hours from infarct symptom 
onset in the majority of cases. 
Limitations. Although the present study represents 
398 Kereiakes et al. 
a large surgical series from which potentially impor- 
tant observations can be made, surgery was per- 
formed on a nonrandom basis without a comparable 
control group for comparison. As the indications for 
bypass surgery following intravenous thrombolysis 
were those used in everyday clinical practice, the ob- 
servations made may have considerable practical ap- 
plication, 
Conclusions. This study evaluates clinical outcome 
and left ventricular function in patients having 
coronary bypass surgery performed as part of a 
sequential myocardial perfusion strategy following 
intravenous thrombolytic therapy during the first 
hospitalization for acute myocardial infarction. Ap- 
proximately one of five patients (22 % ) enrolled into 
the TAM1 1 to 3 and 5 trials had coronary bypass 
surgery during their initial hospitalization. Despite 
older age, more extensive multivessel coronary artery 
disease, more depressed left ventricular function, 
and more frequent occurrence of diabetes mellitus in 
patients having surgery, no difference in hospital 
mortality or incidence of death at long-term follow- 
up of hospital survivors was noted between surgical 
and nonsurgical groups. Patients undergoing bypass 
surgery experienced greater functional recovery in 
global left ventricular ejection fraction and infarct 
zone regional function than did patients treated only 
with intravenous thrombolytic therapy with or with- 
out coronary angioplasty. These data suggest a ben- 
eficial role for coronary bypass surgery with respect 
to recovery of left ventricular function and clinical 
outcome when this procedure is employed as part of 
a sequential reperfusion strategy for patients with 
acute myocardial infarction. 
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